IGF1 and Leigh syndrome: Interestingly, patients in the NPP subgroup with LS and responders without LS started rhIGF1 therapy at a similar age, despite patients in the LS subgroup having a more severe short stature, lower IGF1 levels and higher GH secretion at baseline.